Comstock Resources (CRK) had the highest return between August 11, 2016 and October 30, 2016 by a mid-cap US stock, returning 144.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Comstock Resources (CRK) | 8/11/2016 - 10/30/2016 | 144.34% |
Madrigal Pharmaceuticals (MDGL) | 8/11/2016 - 10/30/2016 | 130.68% |
Merus (MRUS) | 8/11/2016 - 10/30/2016 | 115.2% |
QXO (QXO) | 8/11/2016 - 10/30/2016 | 87.5% |
Sarepta Therapeutics (SRPT) | 8/11/2016 - 10/30/2016 | 68.38% |
Protagonist Therapeutics (PTGX) | 8/11/2016 - 10/30/2016 | 63.92% |
Veracyte (VCYT) | 8/11/2016 - 10/30/2016 | 50.9% |
Light & Wonder (LNW) | 8/11/2016 - 10/30/2016 | 41.27% |
Lantheus (LNTH) | 8/11/2016 - 10/30/2016 | 41% |
Grupo Simec SAB de CV ADR (SIM) | 8/11/2016 - 10/30/2016 | 40.68% |
TAL Education (TAL) | 8/11/2016 - 10/30/2016 | 35.11% |
AAR (AIR) | 8/11/2016 - 10/30/2016 | 34.34% |
Civitas Resources (CIVI) | 8/11/2016 - 10/30/2016 | 31.36% |
International Game Technology (IGT) | 8/11/2016 - 10/30/2016 | 30.01% |
Ascendis Pharma A-S (ASND) | 8/11/2016 - 10/30/2016 | 29.62% |
Alliance Resource Partners (ARLP) | 8/11/2016 - 10/30/2016 | 29.52% |
Catalyst Pharmaceuticals (CPRX) | 8/11/2016 - 10/30/2016 | 29.28% |
Methanex (MEOH) | 8/11/2016 - 10/30/2016 | 29.25% |
TTM Technologies (TTMI) | 8/11/2016 - 10/30/2016 | 28.98% |
Blueprint Medicines (BPMC) | 8/11/2016 - 10/30/2016 | 28.74% |
Nomad Foods (NOMD) | 8/11/2016 - 10/30/2016 | 26.41% |
Gerdau SA ADR (GGB) | 8/11/2016 - 10/30/2016 | 24.51% |
Impinj (PI) | 8/11/2016 - 10/30/2016 | 23.77% |
Piper Sandler Companies (PIPR) | 8/11/2016 - 10/30/2016 | 23.7% |
APA (APA) | 8/11/2016 - 10/30/2016 | 23.56% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
